Optimizing fi bromyalgia management

Nurse Practitioner

Volumn 37, Issue 4, 2012, Pages 12-21

  Firestone, Kari A ^a   Holton, Kathleen F ^a   Mist, Scott D ^a   Wright, Cheryl L ^a   Jones, Kim Dupree ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Chronic pain disorder; Fi bromyalgia; Management of fi bromyalgia

Indexed keywords

ARTICLE; DIFFERENTIAL DIAGNOSIS; FIBROMYALGIA; HUMAN; METHODOLOGY; NURSE PRACTITIONER; NURSING; NURSING ASSESSMENT; PATHOPHYSIOLOGY;

DIAGNOSIS, DIFFERENTIAL; FIBROMYALGIA; HUMANS; NURSE PRACTITIONERS; NURSING ASSESSMENT;

EID: 84860877847     PISSN: 03611817     EISSN: 15388662     Source Type: Journal    
DOI: 10.1097/01.NPR.0000412891.19933.48     Document Type: Article

References (67)

1. Lawerence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the Unites tates. Part II. Arthritis Rheum. 2008;58(1):26-35.
2. Weir PT, Harlan GA, Nkoy, FL, et al. The incidence of fi bromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classifi cation of Disease, 9th Revision CODES. J Clin Rheumatol. 2006;12(3):124-128. (Pubitemid 44314970)
3. Jones KD, Bennett RM, Ward RL, Deodhar AA. Description of a half-day interprofessional fi bromyalgia clinic with an evaluation of patient satisfaction. Am J Phys Med Rehabil. 2011;90(10):825-833.
4. Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L. An Internet survey of 2,596 people with fi bromyalgia. BMC Musculoskel Dis. 2007;8:27.
5. Arnold LM, Crofford LJ, Mease PJ, et al. Patient perspectives on the impact of fi bromyalgia. Patient Educ Couns. 2008;73(1):114-120.
6. Paiva ES, Jones KD. Rational treatment of fi bromyalgia for a solo practitioner Best Pract Res Clin Rheumatol. 2010;24(3):341-352.
7. Hauser W, Kosseva M, Uceyler N, Klose P, Sommer, C. Emotional, physical, and sexual abuse in fi bromyalgia syndrome: a systematic review with metaanalysis. Arthritis Care Res. 2011;63(6):808-820.
8. Buskila D, Atzeni F, Sarzi-Puttini P. Etiology of fi bromyalgia: the possible role of infection and vaccination. Autoimmun Rev. 2008;8(1):41-43.
9. Arnold LM, Hudson JI, Hess EV, et al. Family study of fi bromyalgia. Arthritis Rheum. 2004;50(3):944-952.
10. Kindler LL, Jones KD, Perrin N, Bennett RM. Risk factors predicting the development of widespread pain from chronic back or neck pain. J Pain. 2010;11(12):1320-1328.
11. Williams DA, Clauw DJ. Understanding fi bromyalgia: lessons from the broader pain research community. J Pain. 2009;10(8):777-791.
12. Staud R, Vierck CJ, Cannon RL, Mauderli AP, Price DD. Abnormal sensitization and temporal summation of second pain (wind up) in patients with fi bromyalgia syndrome. Pain. 2001;91(1-2):165-175. (Pubitemid 32274185)
13. Harris RE, Sundgren PC, Pang Y, et al. Dynamic levels of glutamate within the insula are associated with improvements in multiple pain domains in fi bromyalgia. Arthritis Rheum. 2008;58(3):903-907. (Pubitemid 351364893)
14. Desmeules JA, Cedraschi C, Rapiti E, et al. Neurophysiologic evidence for central sensitization in patients with fi bromyalgia. Arthritis Rheum. 2003;48(5):1420-1429. (Pubitemid 36554542)
15. de Souza JB, Potvin S, Goffaux P, Charest J, Marchand S. The defi cit of pain inhibition in fi bromyalgia is more pronounced in patients with comorbid depressive symptoms. Clin J Pain. 2009;25(2):123-127.
16. Bennett RM. Clinical manifestation and diagnosis of fi bromyalgia. Rheum Dis Clin North Am. 2009;35(2):215-232.
17. Arnold LM. The pathophysiology, diagnosis and treatment of fi bromyalgia. Psychiartr Clin North Am. 2010;33(2):375-408.
18. Staud R, Price DD, Robinson ME. The provisional diagnostic criteria for fi bromyalgia: one step forward, two steps back: comment on the article by Wolfe et al. Arthritis Care Res. 2010;62:11 1675-1676.
19. Bennett R, Kamin M, Karin R, Rosenthal N. Tramadol and acetopminophen combin ation tablets in the treatment of fi bromyalgia pain: a double-blind, randomized, placebo-controlled study. Am J Med. 2003;114(7):537-545.
20. Staud R, Price DD, Robinson ME. The provisional diagnostic criteria for fi bromyalgia: one step forward, two steps back: comment on the article by Wolfe et al. Arthritis Care Res. 2010;62(11):1675-1676.
21. Arnold LM, Lu Y, Crofford LJ, et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fi bromyalgia patients with or without major depressive disorder. Arthritis Rheum. 2004;50(9): 2974-2984. (Pubitemid 39209537)
22. Vitton O, Gendreau M, Gendreau J, Kranzler J, Rao SG. A double-blind placebo controlled trial of milnacipran in the treatment of fi bromyalgia. Hum Psychopharmacol. 2004;19(suppl 1):S27-S35. (Pubitemid 39386317)
23. Arnold LM, Keck PE Jr, Welge JA. Antidepressant treatment of fi bromyalgia. A meta-analysis and review. Psychosomatics. 2000;41(2):104-113. (Pubitemid 30159888)
24. Russell IJ, Holman AJ, Swick TJ, Alvarez-Horine S, Wang YG, Guinta D. Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in FM: results from a 14-week, randomized, double-blind, placebo-controlled study. Pain. 2011:152(5):1007-1017.
25. Russell IJ. Fibromyalgia syndrome: approach to management. CNS Spectr. 2008;13(3 suppl 5):27-33 (Pubitemid 351532441)
26. Mease P J, Choy E H. Pharmacotherapy of fi bromyalgia. Rheum.Dis.Clin. North Am 2009;35:359-372.
27. Mease PJ, Russel IJ, Arnold LM, et al. A randomized, double blind, placebo controlled, phase III trial of pregabalin in the treatment of patients with fi bromyalgia. J Pain. 2008;35(3):502-514. (Pubitemid 351374429)
28. Arnold LM, Russell IJ, Diri EW, et al. A 14-week, randomized double blinded, placebo controlled monotherapy trial of pregabalin in patients with fi bromyalgia. J Pain. 2008;9(9):792-805.
29. Casanueva-Fernandez B, Llorca J, Rubio JB, Rodero-Fernandez B, Gonzalez- Gay MA. An effi cacy of a multidisciplinary treatment program in patients with severe fi bromyalgia. Rheumatol Int. 2011 Jul 23. [Epub ahead of print].
30. Jones KD, Deodhar P, Lorentzen A, Bennett RM, Deodhar AA. Growth hormone perturbations in fi bromyalgia: a review. Semin Arthritis Rheum. 2007;36(6):357-379 (Pubitemid 46779123)
31. Elvin A, Siosteen AK, Nilsson A, Kosek E. Decreased muscle blood fl ow in fi bromyalgia patients during standardized muscle exercise: a contrast media enhanced colour Doppler study. Eur J Pain. 2006;10(2):137-144. (Pubitemid 41727764)
32. Staud R, Robinson ME, Price DD. Isometric exercise has opposite effects on central pain mechanisms in fi bromyalgia patients compared to normal controls. Pain. 2005;118(1-2):176-184. (Pubitemid 41566597)
33. Jones KD, Liptan GL. Exercise interventions in fi bromyalgia: clinical applications from the evidence. Rheum Dis Clin North Am. 2009;35(2): 373-391.
34. Bernardy K, Fuber N, Kollner V, Hauser W. Effi cacy of cognitive-behavioral therapies in fi bromyalgia syndrome-a systematic review and meta-analysis of randomized controlled trials. J Rheumatol. 2010;37(10):1991-2005.
35. Bennett R, Nelson D. Cognitive behavioral therapy for fi bromyalgia. Nat Clin Pract Rheumatol. 2006;2:416-424.
36. Mayhew E, Ernst E. Acupuncture for fi bromyalgia-a systematic review of randomized clinical trials. Rheumatology (Oxford). 2007;46(5):801-804. (Pubitemid 47061711)
37. Duncan B, White A, Rahman A. Acupuncture in the treatment of fi bromyalgia in tertiary care: a case series. Acupunct Med. 2007;25(4):137-147. (Pubitemid 351156027)
38. Shaver JL, Wilbur J, Lee H, Robinson FP, Wang E. Self-reported medication and herb/supplement use by women with and without fibromyalgia. J Womens Health (Larchmt). 2009;18(5):709-716.
39. Carson JW, Carson KM, Jones KD, Bennett RM, Wright CL, Mist SD. A randomized controlled clinical trial of the yoga of awareness program in the management of fi bromyalgia. Pain. 2010;151(2):530-539.
40. Wang C, Schmid CH, Rones R, et al. A randomized trial of tai chi for fi bromyalgia. N Engl J Med. 2010;363(8):743-754.
41. Donaldson MS, Speight N, Loomis S. Fibromyalgia syndrome improved using a mostly raw vegetarian diet: an observational study. BMC Complement Altern Med. 2001;1:7.
42. Hanninen O, Kaartinen K, Rauma AL, et al. Antioxidants in vegan diet and rheumatic disorders. Toxicology. 2000;155(1-3):45-53. (Pubitemid 32056313)
43. Kaartinen K, Lammi K, Hypen M, Nenonen M, Hanninen O, Rauma AL. Vegan diet alleviates fi bromyalgia symptoms. Scand J Rheumatol. 2000; 29(5):308-313. (Pubitemid 32014848)
44. Holton KF, Taren DL, Thomson CA, Bennett RM, Jones KD. The effect of dietary glutamate on fi bromyalgia and irritable bowel symptoms. Clin Exper Rheum. 2012. (In Press).
45. Smith JD, Terpening CM, Schmidt SO, Gums JG. Relief of fi bromyalgia symptoms following discontinuation of dietary excitotoxins. Ann Pharmacother. 2001;35(6):702-706. (Pubitemid 32523605)
46. Ciappuccini R, Ansemant T, Maillefert JF, Tavernier C, Ornetti P. Aspartameinduced fi bromyalgia, an unusual but curable cause of chronic pain. Clin Exp Rheumatol. 2010;28(6 suppl 63):S131-S133.
47. Ortancil O, Sanli A, Eryuksel R, Basaran A, Ankarali H. Association between serum ferritin level and fi bromyalgia syndrome. Eur J Clin Nutr. 2010;64(3):308-312.
48. Sendur OF, Tastaban E, Turan Y, Ulman C. The relationship between serum trace element levels and clinical parameters in patients with fi bromyalgia. Rheumatol Int. 2008;28(11):1117-1121.
49. Regland B, Andersson M, Abrahamsson L, Bagby J, Dyrehag LE, Gottfries CG. Increased concentrations of homocysteine in the cerebrospinal fl uid in patients with fi bromyalgia and chronic fatigue syndrome. Scand J Rheumatol. 1997;26(4):301-307. (Pubitemid 27390761)
50. Altindag O, Celik H. Total antioxidant capacity and the severity of the pain in patients with fi bromyalgia. Redox Rep. 2006;11(3):131-135. (Pubitemid 44111109)
51. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classifi cation of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33(2):160-172. (Pubitemid 20098653)
52. Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology of preliminary diagnostic criteria for fi bromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62(5):600-610.
53. Russell IJ, Kamin M, Bennett RM, Schnitzer TJ, Green JA, Katz WA. Effi cacy of tramadol in treatment of pain in fi bromyalgia. J Clin Rheumatol. 2000;6(5):250-257.
54. Goldenberg DL, Burckhardt C, Crofford L. Management of fi bromyalgia syndrome. JAMA. 2004;292(19):2388-2395.
55. Hanninen O, Kaartinen K, Rauma AL, et al. Antioxidants in vegan diet and rheumatic disorders. Toxicology. 2000;155(1-3):45-53. (Pubitemid 32056313)
56. Kaartinen K, Lammi K, Hypen M, Nenonen M, Hanninen O, Rauma AL. Vegan diet alleviates fi bromyalgia symptoms. Scand J Rheumatol. 2000; 29(5):308-313. (Pubitemid 32014848)
57. Holton KF, Taren DL, Thomson CA, Bennett RM, Jones KD. The effect of dietary glutamate on fi bromyalgia and irritable bowel symptoms. Clin Exper Rheum. 2012. (In Press).
58. Smith JD, Terpening CM, Schmidt SO, Gums JG. Relief of fi bromyalgia symptoms following discontinuation of dietary excitotoxins. Ann Pharmacother. 2001;35(6):702-706. (Pubitemid 32523605)
59. Ciappuccini R, Ansemant T, Maillefert JF, Tavernier C, Ornetti P. Aspartameinduced fi bromyalgia, an unusual but curable cause of chronic pain. Clin Exp Rheumatol. 2010;28(6 suppl 63):S131-S133.
60. Ortancil O, Sanli A, Eryuksel R, Basaran A, Ankarali H. Association between serum ferritin level and fi bromyalgia syndrome. Eur J Clin Nutr. 2010;64(3):308-312.
61. Sendur OF, Tastaban E, Turan Y, Ulman C. The relationship between serum trace element levels and clinical parameters in patients with fi bromyalgia. Rheumatol Int. 2008;28(11):1117-1121.
62. Regland B, Andersson M, Abrahamsson L, Bagby J, Dyrehag LE, Gottfries CG. Increased concentrations of homocysteine in the cerebrospinal fl uid in patients with fi bromyalgia and chronic fatigue syndrome. Scand J Rheumatol. 1997;26(4):301-307. (Pubitemid 27390761)
63. Altindag O, Celik H. Total antioxidant capacity and the severity of the pain in patients with fi bromyalgia. Redox Rep. 2006;11(3):131-135. (Pubitemid 44111109)
64. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classifi cation of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33(2):160-172.
65. Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology of preliminary diagnostic criteria for fi bromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62(5):600-610.
66. Russell IJ, Kamin M, Bennett RM, Schnitzer TJ, Green JA, Katz WA. Effi cacy of tramadol in treatment of pain in fi bromyalgia. J Clin Rheumatol. 2000;6(5):250-257.
67. Goldenberg DL, Burckhardt C, Crofford L. Management of fi bromyalgia syndrome. JAMA. 2004;292(19):2388-2395.